A detailed history of Outlook Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Outlook Wealth Advisors, LLC holds 1,243 shares of ABBV stock, worth $207,891. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,243
Previous 1,651 24.71%
Holding current value
$207,891
Previous $255,000 11.37%
% of portfolio
0.08%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $65,206 - $74,296
-408 Reduced 24.71%
1,243 $226,000
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $11,833 - $13,327
86 Added 5.5%
1,651 $255,000
Q2 2023

Jul 10, 2023

BUY
$132.51 - $164.9 $207,378 - $258,068
1,565 New
1,565 $210,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $2,766 - $3,317
-20 Reduced 1.28%
1,540 $249,000
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $3,489 - $4,002
-26 Reduced 1.64%
1,560 $210,000
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $2,614 - $3,324
-19 Reduced 1.18%
1,586 $243,000
Q1 2022

Jul 28, 2022

BUY
$131.98 - $163.75 $211,827 - $262,818
1,605 New
1,605 $261,000
Q4 2020

Feb 04, 2021

SELL
$80.49 - $108.67 $207,503 - $280,151
-2,578 Closed
0 $0
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $50,257 - $58,985
-585 Reduced 18.5%
2,578 $226,000
Q2 2020

Jul 17, 2020

SELL
$73.37 - $98.18 $99,489 - $133,132
-1,356 Reduced 30.01%
3,163 $311,000
Q1 2020

Apr 16, 2020

SELL
$64.5 - $97.79 $57,211 - $86,739
-887 Reduced 16.41%
4,519 $344,000
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $329,994 - $412,893
-4,575 Reduced 45.84%
5,406 $479,000
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $30,734 - $36,951
488 Added 5.14%
9,981 $756,000
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $46,187 - $59,037
703 Added 8.0%
9,493 $690,000
Q1 2019

May 06, 2019

BUY
$77.14 - $90.79 $588,732 - $692,909
7,632 Added 659.07%
8,790 $708,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $90,150 - $111,179
1,158 New
1,158 $1.07 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Outlook Wealth Advisors, LLC Portfolio

Follow Outlook Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Outlook Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Outlook Wealth Advisors, LLC with notifications on news.